Tonix Pharmaceuticals
TNXP
18 hedge funds and large institutions have $25.7M invested in Tonix Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
18% less funds holding
Funds holding: 22 → 18 (-4)
41% less capital invested
Capital invested by funds: $43.7M → $25.7M (-$17.9M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.99M |
| 2 |
BlackRock
New York
|
+$918K |
| 3 |
State Street
Boston,
Massachusetts
|
+$306K |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
+$153K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$3.21M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$1.68M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$366K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$309K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$306K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FDCDDQ
76
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.15K | – | – | – |
|
|
BHWM
77
Beaird Harris Wealth Management
Dallas,
Texas
| $1K | – | – | – |
|
|
GRP
78
Global Retirement Partners
San Rafael,
California
| $1K | – | – | – |
|
|
79
AQR Capital Management
Greenwich,
Connecticut
| – | -$366K | -2 | Closed |
|
|
AFM
80
Anson Funds Management
Dallas,
Texas
| – | -$309K | -1 | Closed |
|
|
CA
81
CoreCap Advisors
Southfield,
Michigan
| – | -$1K | – | – |
|
|
CSS
82
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$3K | – | – |
|
|
CCB
83
Cutter & Co Brokerage
Ballwin,
Missouri
| – | -$7K | – | – |
|
|
HF
84
HRT Financial
New York
| – | -$16K | – | – |
|
|
MSR
85
Main Street Research
Lakeville,
Connecticut
| – | -$7K | – | – |
|
86
Squarepoint
New York
| – | -$12K | – | – |
|
|
VF
87
Virtu Financial
New York
| – | -$110K | – | – |
|
TNXP Hedge Fund Activity: Q1 2022 in Review
18 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2022, worth a combined $25.7M — down 41% from $43.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TNXP and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.99M. The largest seller was D.E. Shaw & Co, cutting an estimated $3.21M.
- 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q1 2022, down from 22 in Q4 2021.
- Funds reported $25.7M of Tonix Pharmaceuticals stock for Q1 2022, down 41% quarter-over-quarter.
- 1 fund opened new Tonix Pharmaceuticals positions in Q1 2022 and 5 closed out, a net change of -4 holders.
- The largest Tonix Pharmaceuticals buyer in Q1 2022 was Renaissance Technologies, an estimated $1.99M added.
- The largest Tonix Pharmaceuticals seller in Q1 2022 was D.E. Shaw & Co, an estimated $3.21M sold.
Based on aggregated 13F filings for Q1 2022.